نتایج جستجو برای: allogeneic hematopoietic stem cell transplantation

تعداد نتایج: 1901277  

2011
Velu Nair Satyaranjan Das Ajay Sharma Sanjeevan Sharma Jasmeet Kaur DK Mishra

INTRODUCTION Diamond-Blackfan anemia and Duchenne muscular dystrophy are two rare congenital anomalies. Both anomalies occurring in the same child is extremely rare. Allogeneic hematopoietic stem cell transplantation is a well-established therapy for Diamond-Blackfan anemia. However, in patients with Duchenne muscular dystrophy, stem cell therapy still remains experimental. CASE PRESENTATION ...

آتشی, امیر, ابراهیمی, لیلا, احمد بیگی, ناصر, امید خدا, آزاده, ذنوبی, زهرا, سلیمانی, مسعود, نیکو گفتار, مهین, کاویانی, سعید,

Background and Objective: Nowadays, although umbilical cord blood is a commonly used source of hematopoietic stem cell, its low frequency of these cells is the main factor limiting its clinical application. The transplantation of hematopoietic stem cells derived from placenta tissue along with umbilical cord blood cells of the same sample may be an appropriate approach to solve this problem. In...

Journal: :iranian journal of blood and cancer 0
s mohammadi m shaiegan ka moghadam gr babaee s samiei a ghavamzadeh

background: it is suggested that ha-1 mismatching among hematopoietic stem cell transplanted recipients-donors is associated with acute graft-versus-host disease (agvhd). so the aim of this study was to evaluate ha-1 frequency and examine the correlation between ha-1 disparity and gvhd patients who received transplantation from a hla-identical sibling. samples and methods: the dna was extracted...

Journal: :iranian journal of public health 0
ensieh nasli esfahani ardeshir ghavamzadeh nika mojahedyazdi seyyedjafar hashemian kamran alimoghadam nar­jes aghel

background: the aim of the present clinical trial was to investigate the efficacy of autologous bone marrow mesenchymal stem cells (bm-mscs) in glycemic control of diabetic patients without using any immunosuppressive drugs over a nine-month period. method: twenty-three patients with t1dm, at 5 to 30 years of age and in both sexes, participated in this study. this trial consisted of two phases;...

Journal: :international journal of hematology-oncology and stem cell research 0
maryam taghizadeh ghehi research center for rational use of drugs, department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran. saeed rezaee department of pharmaceutics, faculty of pharmacy, ahvaz university of medical sciences, ahvaz, iran. alireza hayatshahi clinical pharmacy department, faculty of pharmacy, tehran university of medical sciences, tehran, iran. molouk hadjibabaie research center for rational use of drugs, department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran. kheirollah gholami research center for rational use of drugs, department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran. mohammadreza javadi research center for rational use of drugs, department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran.

background: vancomycin is used abundantly in patients undergoing hsct, especially during neutropenic fever. despite its widespread use little is known about vancomycin pharmacokinetics in hsct patients. we conducted this study to investigate vancomycin pharmacokinetic parameters in our hsct patients and to evaluate current dosing regimen based on trough vancomycin concentrations measurement. me...

Journal: :international journal of hematology-oncology and stem cell research 0
seyed asadollah mousavi hematology-oncology and sct research center, department of hematology-oncology, shariati hospital, tehran university of medical sciences, tehran, iran vahid moazed hematology-oncology and sct research center, department of hematology-oncology, shariati hospital, tehran university of medical sciences, tehran, iran niayesh mohebbi research center for rational use of drugs and department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran molouk hadjibabaie faculty of pharmacy, and research center for rational use of drugs, tehran university of medical sciences, tehran, iran kamran alimoghaddam hematology-oncology and sct research center, department of hematology-oncology, shariati hospital, tehran university of medical sciences, tehran, iran babak bahar hematology-oncology and sct research center, department of hematology-oncology, shariati hospital, tehran university of medical sciences, tehran, iran

abstract background hemorrhagic cystitis(hc)is one of the most challenging complications in hematopoietic stem cell transplantation(hsct). estrogen is one of the suggested treatments for controllingthis problem. material and methods we performed a randomizedcase - controlled study to evaluate the efficacy of oral conjugated estrogen on hc management in 56hsct patients.patients were randomly ass...

2014
Lu-Hong Xu Jian-Pei Fang Wen-Jun Weng Hong-Gui Xu

OBJECTIVE Humoral immunity has been clearly implicated in solid organ transplantation, but little is known about the relationship between humoral immunity and hematopoietic stem cell transplantation. This study was designed to investigate that relationship. MATERIALS AND METHODS Sensitized serum was obtained from a sensitized murine model established by allogeneic splenocyte transfusion. Sens...

2015

Hematopoietic stem-cell transplantation refers to a procedure in which hematopoietic stem cells are infused to restore bone marrow function in cancer patients who receive bone-marrow-toxic doses of cytotoxic drugs with or without whole-body radiation therapy. Hematopoietic stem cells may be obtained from the transplant recipient (autologous HSCT) or from a donor (allogeneic HSCT). They can be h...

2016

Hematopoietic stem-cell transplantation (HSCT) refers to a procedure in which hematopoietic stem cells are infused to restore bone marrow function in cancer patients who receive bone-marrowtoxic doses of cytotoxic drugs with or without whole-body radiation therapy. Hematopoietic stem cells may be obtained from the transplant recipient (autologous HSCT) or from a donor (allogeneic HSCT). They ca...

2014
JAVIER MUNOZ NINA SHAH KATAYOUN REZVANI CHITRA HOSING CATHERINE M. BOLLARD BETUL ORAN AMANDA OLSON UDAY POPAT JEFFREY MOLLDREM IAN K. MCNIECE ELIZABETH J. SHPALL

Allogeneic hematopoietic stem cell transplantation is an important treatment option for fit patients with poor-risk hematological malignancies; nevertheless, the lack of available fully matched donors limits the extent of its use. Umbilical cord blood has emerged as an effective alternate source of hematopoietic stem cell support. Transplantation with cord blood allows for faster availability o...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید